DUBLIN, May 1, 2017 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that Paul Campanelli, President and CEO, is scheduled to present at the UBS Global Healthcare Conference in New York on Tuesday, May 23, 2017 at 8 a.m. EDT.
About Endo International plcEndo International plc (NASDAQ: ENDP) is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endo-to-present-at-ubs-global-healthcare-conference-300448298.html
SOURCE Endo International plc
Subscribe to our Free Newsletters!
Learn the basics about diabetes and how to bring it under control with turmeric, an highly ...
Antioxidants are artificial or natural components that help protect the human body from the damage ...
Angiogenesis is the process of formation of new blood vessels from pre-existing blood vessels. It ...View All